Identification of a human non-interferon lymphokine activating monocyte complement biosynthesis

Biochem J. 1989 Oct 1;263(1):157-64. doi: 10.1042/bj2630157.

Abstract

A monocyte-stimulating activity produced by mitogen-induced mononuclear cells has been defined by its ability to enhance the synthesis in vitro of complement C1 subcomponents, C2 and C3. A lymphokine responsible for this activity was purified from culture supernatants of peripheral blood mononuclear cells activated by staphylococcal enterotoxin A. From 0.5 litre of supernatant the purification procedure [(NH4)2SO4 precipitation, phenyl-Sepharose chromatography and preparative electrofocusing] yielded about 100 pmol of purified lymphokine. Its pI is 7.9 and its Mr, estimated by SDS/polyacrylamide-gel electrophoresis, is 14,600, 27,000 and 56,000, the high-Mr species representing oligomeric forms of the Mr-14,600 molecule. Its amino acid analysis reveals a high percentage of hydrophobic amino acids (34%); the absence of histidine residues suggests that it is a novel monocyte-activating lymphokine. It enhances C1r and C1s biosynthesis at a pretranslational level. From its structure and activity this lymphokine appears different from gamma-interferon.

MeSH terms

  • Amino Acids / analysis
  • Cell-Free System
  • Chromatography, Gel
  • Complement Activation*
  • Complement C1 / biosynthesis*
  • DNA / analysis
  • DNA Probes
  • Electrophoresis, Polyacrylamide Gel
  • Humans
  • Interferon-gamma / pharmacology
  • Interferons / isolation & purification
  • Interferons / pharmacology*
  • Isoelectric Point
  • Lymphokines / isolation & purification
  • Lymphokines / pharmacology*
  • Monocytes / metabolism*
  • Precipitin Tests
  • Protein Biosynthesis
  • RNA / genetics
  • RNA / isolation & purification
  • Recombinant Proteins

Substances

  • Amino Acids
  • Complement C1
  • DNA Probes
  • Lymphokines
  • Recombinant Proteins
  • RNA
  • Interferon-gamma
  • DNA
  • Interferons